A risk model developed based on necroptosis to assess progression for ischemic cardiomyopathy and identify possible therapeutic drugs

Object: Ischemic cardiomyopathy (ICM), with high morbidity and mortality, is the most common cause of heart failure. Cardiovascular remodeling secondary to chronic myocardial ischemia is the main cause of its progression. A recently identified type of programmed cell death called necroptosis is cruc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yang, Wang, Dashuai, Zhu, Yaoxi, Du, Yimei, Zhang, Jinying, Yang, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744324/
https://www.ncbi.nlm.nih.gov/pubmed/36518671
http://dx.doi.org/10.3389/fphar.2022.1039857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744324/
https://www.ncbi.nlm.nih.gov/pubmed/36518671
http://dx.doi.org/10.3389/fphar.2022.1039857

Ejemplares similares